Pazopanib cancer drug

Pazopanib cancer drug

C038/7538 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.1MB

Downloadable file size: 1.9MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Pazopanib cancer drug. 400mg tablets of the anti-cancer drug pazopanib, marketed under the name Votrient. Pazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis, the production of new blood vessels. It is used to treat renal cell (kidney) carcinoma and soft tissue sarcoma.

Release details: Model release not required. Property release not required.

Keywords: 400mg, blue background, cancer, cancers, caplet, caplets, drug, drugs, healthcare, kidney cancer, medical, medicine, multi-targeted, no-one, nobody, oncological, oncology, pazopanib, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pill, pills, prescribed, prescription, receptor tyrosine kinase inhibitor, renal, renal cell carcinoma, selective, soft tissue sarcoma, still life, still-life, votrient

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.